000 | 01919 a2200577 4500 | ||
---|---|---|---|
005 | 20250517193130.0 | ||
264 | 0 | _c20180822 | |
008 | 201808s 0 0 eng d | ||
022 | _a2044-6055 | ||
024 | 7 |
_a10.1136/bmjopen-2017-019170 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPavlinac, Patricia B | |
245 | 0 | 0 |
_aAzithromycin to prevent post-discharge morbidity and mortality in Kenyan children: a protocol for a randomised, double-blind, placebo-controlled trial (the Toto Bora trial). _h[electronic resource] |
260 |
_bBMJ open _c12 2017 |
||
300 |
_ae019170 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
650 | 0 | 4 |
_aAzithromycin _xtherapeutic use |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aDrug Resistance, Microbial |
650 | 0 | 4 | _aEscherichia coli |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHospitalization |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 | _aInfant Death |
650 | 0 | 4 |
_aInfections _xdrug therapy |
650 | 0 | 4 | _aKenya |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMorbidity |
650 | 0 | 4 | _aPatient Discharge |
650 | 0 | 4 | _aPatient Readmission |
650 | 0 | 4 | _aProportional Hazards Models |
650 | 0 | 4 | _aResearch Design |
650 | 0 | 4 | _aStreptococcus pneumoniae |
700 | 1 | _aSinga, Benson O | |
700 | 1 | _aJohn-Stewart, Grace C | |
700 | 1 | _aRichardson, Barbra A | |
700 | 1 | _aBrander, Rebecca L | |
700 | 1 | _aMcGrath, Christine J | |
700 | 1 | _aTickell, Kirkby D | |
700 | 1 | _aAmondi, Mary | |
700 | 1 | _aRwigi, Doreen | |
700 | 1 | _aBabigumira, Joseph B | |
700 | 1 | _aKariuki, Sam | |
700 | 1 | _aNduati, Ruth | |
700 | 1 | _aWalson, Judd L | |
773 | 0 |
_tBMJ open _gvol. 7 _gno. 12 _gp. e019170 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmjopen-2017-019170 _zAvailable from publisher's website |
999 |
_c27937046 _d27937046 |